Keran Ma

Keran Ma

Auto-generated profile, based on publicly available information

Keran Ma

Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Neurobiology and Anatomy, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Neuron
Verified
Journal Article
Closed access
MMMagdalena Martinez-Losa
Magdalena Martinez-Losa
TTTara E. Tracy
Tara E. Tracy
KMKeran Ma
Keran Ma
LVLaure Verret
Laure Verret
ACAlexandra Clemente-Perez
Alexandra Clemente-Perez
JPJorge J. Palop
Jorge J. Palop

11 October 2012 in Brain
Verified
Journal Article
Closed access
PDF file
ADAdrienne Dorr
Adrienne Dorr
BSBhupinder Sahota
Bhupinder Sahota
LCLakshminarayan V. Chinta
Lakshminarayan V. Chinta
MBMary E. Brown
Mary E. Brown
ALAaron Y. Lai
Aaron Y. Lai
BSBojana Stefanovic
Bojana Stefanovic
The majority of patients with Alzheimer’s disease have cerebral amyloid angiopathy, thus showing deposition of amyloid-β peptides in the walls of leptomeningeal and cortical arterioles. These deposits are believed to result from impaired clearance of parenchymal amyloid-β peptides. In the current work, we examined the changes in cortical microvascular structure and function in situ in TgCRND8, a transgenic mouse model of Alzheimer’s disease. In contrast to venules, cortical arterioles were shown to increase in tortuosity and decrease in calibre with amyloid-β peptide accumulation. These structural changes were accompanied by progressive functional compromise, reflected in higher dispersion of microvascular network transit times, elongation of the transit times, and impaired microvascular reactivity to hypercapnia in the transgenic mice. Moreover, inhibition of amyloid-β peptide oligomerization and fibrillization via post-weaning administration of scyllo-inositol, a naturally occurring stereoisomer of myo-inositol, rescued both structural and functional impairment of the cortical microvasculature in this Alzheimer’s disease model. These results demonstrate that microvascular impairment is directly correlated with amyloid-β accumulation and highlight the importance of targeting cerebrovascular amyloid angiopathy clearance for effective diagnosis, monitoring of disease progression and treatment of Alzheimer’s disease.

1 January 2012
Verified
Book Chapter
Closed access
KMKeran Ma
Keran Ma
LTLynsie A.M. Thomason
Lynsie A.M. Thomason
JMJoAnne McLaurin
JoAnne McLaurin

14 May 2014 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
KMKeran Ma
Keran Ma
JMJoAnne McLaurin
JoAnne McLaurin
In Alzheimer's disease (AD), appropriate excitatory–inhibitory balance required for memory formation is impaired. Our objective was to elucidate deficits in the inhibitory GABAergic system in the TgCRND8 mouse model of AD to establish a link between GABAergic dysfunction and cognitive function. We sought to determine whether the neuroprotective peptide α-melanocyte stimulating hormone (α-MSH) attenuates GABAergic loss and thus improves cognition. TgCRND8 mice with established β-amyloid peptide pathology and nontransgenic littermates were treated with either α-MSH or vehicle via daily intraperitoneal injections for 28 d. TgCRND8 mice exhibited spatial memory deficits and altered anxiety that were rescued after α-MSH treatment. The expression of GABAergic marker glutamic acid decarboxylase 67 (GAD67) and the number of GABAergic GAD67+ interneurons expressing neuropeptide Y and somatostatin are reduced in the hippocampus in vehicle-treated TgCRND8 mice. In the septohippocampal pathway, GABAergic deficits are observed before cholinergic deficits, suggesting that GABAergic loss may underlie behavior deficits in vehicle-treated TgCRND8 mice. α-MSH preserves GAD67 expression and prevents loss of the somatostatin-expressing subtype of GABAergic GAD67+ inhibitory interneurons. Without decreasing β-amyloid peptide load in the brain, α-MSH improves spatial memory in TgCRND8 mice and prevents alterations in anxiety. α-MSH modulated the excitatory–inhibitory balance in the brain by restoring GABAergic inhibition and, as a result, improved cognition in TgCRND8 mice.

10 June 2014 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
WYWenfeng Yu
Wenfeng Yu
MBMathilde Bonnet
Mathilde Bonnet
MFMark Farso
Mark Farso
KMKeran Ma
Keran Ma
JCJean-Guy Chabot
Jean-Guy Chabot
Slavica KranticSlavica Krantic
Slavica Krantic
Recent evidence has suggested that Alzheimer’s disease (AD)-associated neuronal loss may occur via the caspase-independent route of programmed cell death (PCD) in addition to caspase-dependent mechanisms. However, the brain region specificity of caspase-independent PCD in AD-associated neurodegeneration is unknown. We therefore used the transgenic CRND8 (TgCRND8) AD mouse model to explore whether the apoptosis inducing factor (AIF), a key mediator of caspase-independent PCD, contributes to cell loss in selected brain regions in the course of aging.

29 March 2011 in Neuroscience Letters
Verified
Journal Article
Closed access
KMKeran Ma
Keran Ma
HMHoward T.J. Mount
Howard T.J. Mount
JMJoAnne McLaurin
JoAnne McLaurin